Not applicableUnknownNCT06119763What this trial is testingAntiDFS70 Lupus NephritisWho this might be right forSystemic Lupus Erythematosus Sohag University 50
Large-scale testing (Phase 3)Study completedNCT02420821What this trial is testingAtezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Hoffmann-La Roche 915
Early research (Phase 1)Study completedNCT00938626What this trial is testingTreated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Barbara Ann Karmanos Cancer Institute 12
Large-scale testing (Phase 3)Study completedNCT02813785What this trial is testingAtezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing ChemotherapyWho this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 565
Not applicableStudy completedNCT06607809What this trial is testingInflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCCWho this might be right forMetastatic Renal Cell Carcinoma Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Testing effectiveness (Phase 2)Ended earlyNCT03781414What this trial is testingStudy of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term ExtensionWho this might be right forLiver Transplant Rejection Novartis Pharmaceuticals 129
Not applicableUnknownNCT05745948What this trial is testingCOVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CFWho this might be right forCOVID-19Cystic Fibrosis Hospital Universitari Vall d'Hebron Research Institute 150
Testing effectiveness (Phase 2)Study completedNCT00443326What this trial is testingAMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsWho this might be right forPsoriasis Amgen 22
Not applicableEnded earlyNCT04799392What this trial is testingNOWDx Test for the Detection of Antibodies to COVID-19 in Lay PersonsWho this might be right forCOVID-19SARS-CoV-2Coronavirus NOWDiagnostics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00301899What this trial is testingTrastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TrastuzumabWho this might be right forBreast Cancer National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT00410163What this trial is testingOfatumumab With Fludarabine and Cyclophosphamide in B-CLL PatientsWho this might be right forLeukaemia, Lymphocytic, Chronic GlaxoSmithKline 61
Early research (Phase 1)Study completedNCT05166421What this trial is testingStudy to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy ParticipantsWho this might be right forCorona Virus Disease AstraZeneca 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416984What this trial is testingSafety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)Who this might be right forRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Allogene Therapeutics 160
Not applicableStudy completedNCT03098238What this trial is testingEndothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney TransplantationWho this might be right forRenal Transplantation University Hospital, Montpellier 249
Not applicableStudy completedNCT05357885What this trial is testingQuantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary BypassWho this might be right forLaboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary Bypass Thomas Jefferson University 60
Not applicableActive Not RecruitingNCT04964271What this trial is testingIdentification of Prostate Cancer Specific Markers in Patients Compared to Healthy ParticipantsWho this might be right forProstatic Neoplasms Tethis S.p.A. 60
Not applicableWithdrawnNCT02099149What this trial is testingAntibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 DaysWho this might be right forInvasive Group B Streptococcus Disease Novartis
Early research (Phase 1)Study completedNCT02262338What this trial is testingSafety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter SyndromeWho this might be right forMucopolysaccharidosis II ArmaGen, Inc 6
Testing effectiveness (Phase 2)Ended earlyNCT00969722What this trial is testingMAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma PatientsWho this might be right forPrimary Refractory Neuroblastoma United Therapeutics 1
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147